{{Rsnum
|rsid=17174870
|Gene=MERTK
|Chromosome=2
|position=111907624
|Orientation=plus
|GMAF=0.2181
|Gene_s=MERTK
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 51.3 | 44.2 | 4.4
| HCB | 83.9 | 16.1 | 0.0
| JPT | 73.2 | 24.1 | 2.7
| YRI | 66.4 | 30.8 | 2.7
| ASW | 73.7 | 22.8 | 3.5
| CHB | 83.9 | 16.1 | 0.0
| CHD | 79.8 | 18.3 | 1.8
| GIH | 27.7 | 46.5 | 25.7
| LWK | 70.9 | 27.3 | 1.8
| MEX | 36.2 | 53.4 | 10.3
| MKK | 58.7 | 35.5 | 5.8
| TSI | 63.7 | 33.3 | 2.9
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21833088
|Trait=None
|Title=Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis.
|RiskAllele=G
|Pval=1E-8
|OR=1.1100
|ORtxt=[1.09-1.13]
|OA=1
}}

{{PMID Auto
|PMID=21347448
|Title=Polymorphisms in the receptor tyrosine kinase MERTK gene are associated with multiple sclerosis susceptibility.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}